Orasis seals $30m Series C
Orasis Pharmaceuticals, an emerging ophthalmic pharmaceutical company, has raised $30 million in Series C financing.
Orasis Pharmaceuticals, an emerging ophthalmic pharmaceutical company, has raised $30 million in Series C financing.
Copyright PEI Media
Not for publication, email or dissemination